Bausch Health Companies (BHC) Cash from Investing Activities (2009 - 2026)

Bausch Health Companies (BHC) has 18 years of Cash from Investing Activities data on file, last reported at -$139.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 6.92% year-over-year to -$139.0 million; the trailing twelve-month figure through Mar 2026 stood at -$604.0 million (down 18.2% YoY), and the FY2025 full-year result was -$595.0 million, down 31.06% from the prior year.
• Cash from Investing Activities rose to -$139.0 million in Q1 2026, from -$282.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$30.0 million in Q2 2023 to a low of -$1.9 billion in Q3 2023.
• A 5-year average of -$213.9 million and a median of -$100.0 million in 2025 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities slumped 3464.15% in 2023 and jumped 94.6% in 2024, its largest moves.
• Tracing BHC's Cash from Investing Activities over 5 years: stood at -$136.0 million in 2022, then slipped by 8.82% to -$148.0 million in 2023, then slumped by 35.14% to -$200.0 million in 2024, then tumbled by 41.0% to -$282.0 million in 2025, then jumped by 50.71% to -$139.0 million in 2026.
• Business Quant data shows BHC's Cash from Investing Activities at -$139.0 million in Q1 2026, -$282.0 million in Q4 2025, and -$83.0 million in Q3 2025.